Nykode Therapeutics AS (VACBF) News Today $0.21 0.00 (0.00%) As of 09/12/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort InterestBuy This Stock VACBF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Nykode Therapeutics AS (VACBF) Q2 2025 Earnings Call Highlights: From Net Loss to Profit Amid ...August 28, 2025 | finance.yahoo.comVACBF | Nykode Therapeutics A/S Annual Cash Flow Statement - MarketWatchJuly 2, 2025 | marketwatch.comVACBF Nykode Therapeutics AS - Seeking AlphaJuly 1, 2025 | seekingalpha.comNykode Therapeutics AS (VACBF) - Yahoo FinanceJune 26, 2025 | au.finance.yahoo.comNykode Therapeutics AS (VACBF) Q1 2025 Earnings Call Highlights: Strategic Streamlining and ...May 29, 2025 | gurufocus.comQ1 2025 Nykode Therapeutics ASA Earnings Call TranscriptMay 28, 2025 | gurufocus.comNykode Therapeutics AS (VACBF) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...February 27, 2025 | finance.yahoo.comMan City news: Erling Haaland investment can’t save ailing vaccine companyJanuary 21, 2025 | msn.comNykode Therapeutics AS (VACBF) Q3 2024 Earnings Call Highlights: Strategic Shifts and Financial ...November 28, 2024 | gurufocus.comQ3 2024 Nykode Therapeutics ASA Earnings Call TranscriptNovember 27, 2024 | gurufocus.comNykode Therapeutics And 2 More Penny Stocks Worth WatchingNovember 20, 2024 | finance.yahoo.comNykode Therapeutics Announces Updates on its Inverse Vaccine Platform at PEGS EuropeNovember 6, 2024 | globenewswire.comNykode Therapeutics AS (5VB.DU)September 17, 2024 | finance.yahoo.comNykode Therapeutics Announces Issuance of Key Patent Covering Individualized Neoantigen Based VaccinesAugust 14, 2024 | globenewswire.comNykode Therapeutics Announces Updates on its Inverse Vaccine Platform at FOCIS 2024 MeetingJune 20, 2024 | globenewswire.comNykode Therapeutics Announces mRNA-LNP Cancer Vaccine Demonstrates Superior EfficacyJune 11, 2024 | globenewswire.comNykode Therapeutics Announces Clinical Collaboration with MSD to Evaluate VB10.16 in Combination with KEYTRUDA® (pembrolizumab) in Patients with HPV16-Positive High-Risk Locally Advanced Cervical CancerMay 14, 2024 | globenewswire.comNykode Therapeutics - Quarterly report Q1 2024May 14, 2024 | globenewswire.comNykode Therapeutics Initiates Phase 2 Trial of VB10.16 in Second Line HPV16-Positive Cervical CancerApril 19, 2024 | globenewswire.comNykode Therapeutics Announces Topline Conclusions Affirming Prolonged Clinical Benefits from Matured Survival Data in Phase 2 C-02 Trial in Advanced Cervical CancerMarch 21, 2024 | globenewswire.comNykode Therapeutics Announces Advances in the Inverse Vaccine Platform With the Potential to Treat Autoimmune DiseasesMarch 19, 2024 | globenewswire.comNykode Therapeutics - Quarterly report Q3 2023January 29, 2024 | finance.yahoo.com Get Nykode Therapeutics AS News Delivered to You Automatically Sign up to receive the latest news and ratings for VACBF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VACBF Media Mentions By Week VACBF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VACBF News Sentiment▼0.000.94▲Average Medical News Sentiment VACBF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VACBF Articles This Week▼00▲VACBF Articles Average Week Get the Latest News and Ratings for VACBF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Nykode Therapeutics AS and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies SXTPW News Today AGNPF News Today AKBLF News Today DRTSW News Today ASPHF News Today ASCLF News Today AVCTF News Today AWKNF News Today BRRGF News Today BCTXW News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:VACBF) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nykode Therapeutics AS Please log in to your account or sign up in order to add this asset to your watchlist. Share Nykode Therapeutics AS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
